Complement regulatory proteins at the feto‐maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein(CD46) and decay accelerating factor (CD55)
Authors:
- Noriko OkadaNONoriko Okada
- 1 June 1992
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 22 (6) , 1579-1585
Abstract
The complement (C) regulatory proteins decay‐accelerating factor (DAF, CD55)and membrane cofactor protein (MCP, CD46), which control C3 convertases, together with CD59, an inhibitor of the membrane attack complex (MAC), were found to be present in the developing human placenta from at least 6 weeks of gestation until term. Immunostaining revealed differences in the distribution of these proteins on the fetally derived trophoblast epithelium, especially in early placentae which contain trophoblast populations of diverse proliferative potential and differentiation status. Expression of all three proteins occurred on the terminally differentiated syncytiotrophoblast epithelium covering chorionic villi and which is in direct contact with maternal blood. CD59 was also expressed on the underlying villous cytotrophoblast cells and on their extra‐villous derivatives. These two populations showeddifferential expression of the C3 convertase regulators. Villous cytotrophoblast cells expressed MCP but were largely devoid of DAF. Proliferation of this population to generate extra‐villous cytotrophoblast cellcolumns was associated with both an increase in DAF expression and a decrease in MCP expression. Throughout placental development, expression of DAF appeared to be lower than that of MCP and CD59 as assessed by solid‐phase binding assays on isolated trophoblast membranes. Early placentae were also found to contain both DAF+ and DAF− chorionic villi. Conversely, expression of CD59 appeared comparatively high and transcripts for CD59 were found to be much more abundant than those for DAF in purified trophoblast cells. C regulatory proteins appear to play an important role throughout gestation in protectingthe fetally derived human conceptus from maternal C. The differential expression patterns of the proteins on trophoblast may reflect differences in requirement for specific functional activities at different locations within the placenta.Keywords
This publication has 34 references indexed in Scilit:
- 20 KDa homologous restriction factor of complement resembles T cell activating proteinBiochemical and Biophysical Research Communications, 1989
- Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.Journal of Clinical Investigation, 1989
- A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complementInternational Immunology, 1989
- Characterization of a broadly expressed human leucocyte surface antigen MEM-43 anchored in membrane through phosphatidylinositolMolecular Immunology, 1989
- MATERNAL IMMUNE RESPONSES TO THE FETUS IN EARLY PREGNANCY AND RECURRENT MISCARRIAGEThe Lancet, 1988
- Structure, Organization, and Regulation of the Complement GenesAnnual Review of Immunology, 1988
- IS ANTIPATERNAL CYTOTOXIC ANTIBODY A VALID MARKER IN THE MANAGEMENT OF RECURRENT ABORTION?The Lancet, 1987
- Separation of self from non-self in the complement systemImmunology Today, 1987
- Hu Ly-m5: A unique antigen physically associated with HLA moleculesHuman Immunology, 1983
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970